CYH (Community Health Systems, Inc.)
Insider Trading Activity
Every open-market purchase and sale reported by CYH officers, directors and 10%+ beneficial owners on SEC Form 4, which must be filed within two business days of the transaction. Sales often reflect scheduled 10b5-1 plans or tax withholding rather than a directional view, so read counts alongside the size and the filer.
Market data may be delayed, incomplete, or inaccurate. Not a recommendation to buy, sell, or hold any security. Verify quotes with your broker before trading. See Terms §17.
| Filed | Insider | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-25 | WILLIAM NORRIS JENNINGS | Director | Sell | — | — |
| 2026-06-01 | David V. Rice | EVP-Clinical Operations & CMO | A | — | — |
| 2026-04-22 | K Ranga Krishnan | Director | M | — | — |
| 2026-03-03 | Joseph Arthur Hastings | Director | A | — | — |
| 2026-03-03 | FAWN D LOPEZ | Director | A | — | — |
| 2026-03-03 | Hubert James Williams | Director | M | — | — |
| 2026-03-03 | James S. Ely III | Director | M | — | — |
| 2026-03-03 | WAYNE T SMITH | Director | G | — | — |
| 2026-03-03 | RONALD L BURGESS JR | Director | A | — | — |
| 2026-03-03 | K Ranga Krishnan | Director | A | — | — |
| 2026-03-03 | Phillip A. Posey | SVP & CAO | MIXED | — | — |
| 2026-03-03 | Elizabeth T Hirsch | Director | M | — | — |
| 2026-03-03 | JOHN A CLERICO | Director | M | — | — |
| 2026-03-03 | KEVIN A STOCKTON | EVP, Operations & Development | MIXED | — | — |
| 2026-03-03 | MICHAEL DINKINS | Director | M | — | — |
| 2026-03-03 | WILLIAM NORRIS JENNINGS | Director | A | — | — |
| 2026-03-03 | Jason K Johnson | EVP & CFO | MIXED | — | — |
| 2026-03-03 | JOHN A FRY | Director | M | — | — |
| 2026-03-03 | KEVIN J HAMMONS | CEO | MIXED | — | — |
| 2026-03-03 | Susan W Brooks | Director | M | — | — |
| 2026-03-03 | Justin D Pitt | Pres,Chief Legal&Admin Officer | MIXED | — | — |
| 2025-12-31 | James S. Ely III | Director | M | — | — |
| 2025-06-02 | Susan W Brooks | Director | M | — | — |
| 2025-03-03 | WILLIAM NORRIS JENNINGS | Director | A | — | — |
| 2025-03-03 | K Ranga Krishnan | Director | A | — | — |
| 2025-03-03 | JOHN A CLERICO | Director | M | — | — |
| 2025-03-03 | FAWN D LOPEZ | Director | A | — | — |
| 2025-03-03 | James S. Ely III | Director | M | — | — |
| 2025-03-03 | RONALD L BURGESS JR | Director | A | — | — |
| 2025-03-03 | MARK B MEDLEY | Regional President | MIXED | — | — |
| 2025-03-03 | AUSTEN D MASON | Regional President | MIXED | — | — |
| 2025-03-03 | KEVIN A STOCKTON | EVP, Operations & Development | MIXED | — | — |
| 2025-03-03 | CHAD A CAMPBELL | Regional President | MIXED | — | — |
| 2025-03-03 | MIGUEL S BENET | President and CMO | MIXED | — | — |
| 2025-03-03 | Justin D Pitt | Pres,Chief Legal&Admin Officer | MIXED | — | — |
| 2025-03-03 | Tim Hingtgen | CEO | MIXED | — | — |
| 2025-03-03 | Joseph Arthur Hastings | Director | A | — | — |
| 2025-03-03 | MICHAEL DINKINS | Director | M | — | — |
| 2025-03-03 | Susan W Brooks | Director | M | — | — |
| 2025-03-03 | Hubert James Williams | Director | M | — | — |
| 2025-03-03 | WAYNE T SMITH | Director | M | — | — |
| 2025-03-03 | JOHN A FRY | Director | M | — | — |
| 2025-03-03 | Jason K Johnson | SVP & CAO | MIXED | — | — |
| 2025-03-03 | KEVIN J HAMMONS | President and CFO | MIXED | — | — |
| 2025-03-03 | Elizabeth T Hirsch | Director | M | — | — |
| 2025-02-25 | MIGUEL S BENET | President and CMO | Sell | — | — |
| 2025-02-21 | WAYNE T SMITH | Director | G | — | — |
| 2024-06-03 | FAWN D LOPEZ | Director | A | — | — |
| 2024-06-03 | Susan W Brooks | Director | M | — | — |
| 2024-03-15 | Justin D Pitt | EVP and General Counsel | D | — | — |
| Insider | Role | Shares Held | Value |
|---|---|---|---|
| — | 10%+ Owner | 26,840,906 | — |
| — | 10%+ Owner | 15,640,785 | — |
| — | 10%+ Owner | 14,646,441 | — |
| — | 10%+ Owner | 10,984,473 | — |
| — | Director | 5,699,300 | — |
| — | CEO | 1,467,588 | — |
| — | CEO | 895,545 | — |
| — | President and CMO | 482,657 | — |
| — | Director | 397,933 | — |
| — | Director | 327,924 | — |
| — | Pres,Chief Legal&Admin Officer | 325,256 | — |
| — | Division President | 321,777 | — |
| — | EVP and General Counsel | 293,633 | — |
| — | Executive VP and CFO | 281,677 | — |
| — | Division President - Group Ops | 268,461 | — |
| — | Director | 249,033 | — |
| — | EVP and CFO | 241,515 | — |
| — | Director | 225,882 | — |
| — | Director | 211,863 | — |
| — | EVP, Operations & Development | 208,290 | — |
| — | EVP & CFO | 202,049 | — |
| — | Director | 162,059 | — |
| — | Director | 162,056 | — |
| — | Director | 156,093 | — |
| — | Regional President | 150,787 | — |
Form 4 reports a change in beneficial ownership by an officer, director or 10%+ holder, and must be filed within two business days of the transaction — so this is close to real time, unlike the 45-day-lagged 13F institutional data.
Transaction codes matter more than the raw buy/sell count. Code P is an open-market purchase — an insider choosing to buy with their own money, which is the signal most research treats as informative. Code S is a sale, but sales are frequently pre-scheduled under a 10b5-1 plan or cover tax withholding on vesting equity, so a run of sales often says nothing directional. Codes A and M are grants and option exercises rather than open-market decisions.
Full filing history and per-insider positions are on the CYH quote page; the site-wide leaderboard is on the insider transactions hub.